PROTECT AKTIENANLEIHE - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 11:22:37 17/05/2024 pm IST | ||
| 101 USD | -0.23% |
|
| Current month | -0.32% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 101 | -0.23% |
| 16/24/16 | 101.2 | -0.36% |
| 15/24/15 | 101.6 | +0.93% |
| 14/24/14 | 100.6 | +0.23% |
| 13/24/13 | 100.4 | -0.31% |
Real-time Boerse Frankfurt Warrants
Last update May 17, 2024 at 11:22 pm IST
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| WKN | VD4CR2 |
| ISIN | DE000VD4CR24 |
| Date issued | 18/04/2024 |
| Strike | 753.5 $ |
| Maturity | 22/04/2025 (339 Days) |
| Parity | 0.75 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 101.6 $ |
|---|---|
| Lowest since issue | 98.09 $ |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
770
USD
Average target price
850.4
USD
Spread / Average Target
+10.44%
- Stock Market
- Certificates
- Certificat
